Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Santen Pharmaceutical Co., Ltd.

SNPHF•PNK
Healthcare
Drug Manufacturers - General
$9.51
$0.00(0.00%)
U.S. Market opens in 6h 50m

Santen Pharmaceutical Co., Ltd. (SNPHF) Stock Overview

Explore Santen Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio15.45
EPS (TTM)$0.59
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$9.26
3 Months$8.92
1 Year Target$10.34

SNPHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Santen Pharmaceutical Co., Ltd. (SNPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.45 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-5.93%
6-Month Change
-16.94%
Year-to-Date (YTD) Change
N/A
1-Year Change
-9.69%
3-Year Change
24.97%
5-Year Change
-36.39%
All-Time (Max) Change
-99.53%

Contact Information

https://www.santen.com
81 6 7664 8621
Grand Front Osaka Tower A, Osaka, NaN, 530-8552

Company Facts

37,440 Employees
IPO DateJun 9, 2010
CountryJP
Actively Trading

Frequently Asked Questions